Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3), Oral Ecnoglutide (Phase 1), and Novel Amylin Analogs at the American Diabetes Association (ADA) 84th Annual Conference

PR Newswire
June 22, 2024 — 07:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America Hangzhou manufacturing

Related News:

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024 — 08:18

Desay Battery Highlights Advanced Energy Solutions at RE+ 2024

September 11, 2024 — 03:00

Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

August 29, 2024 — 14:31

2024 Belt and Road Journalists Forum to Be Held in Chongqing

August 25, 2024 — 17:50

Hisense and Black Myth: Wukong Redefine the Standard for 3A Gaming Experiences on Large Screens

August 24, 2024 — 00:55

WSPN Appoints Ex-Visa President John Partridge as Board Director

August 22, 2024 — 11:22

Midea Group Reports a Record-Breaking RMB 20 Billion in H1 Profits

August 20, 2024 — 11:49

PRA Group Leader Wins Silver Stevie Award in 2024 International Business Awards

August 16, 2024 — 06:31

CHIVAS REGAL SCORES BIG WITH MULTI-YEAR GLOBAL ARSENAL PARTNERSHIP

August 15, 2024 — 01:30

Franchising and Licensing Asia (FLAsia) 2024